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ABSTRACT
OBJECTIVE: To discuss factors related to the financing of the Basic Component of Pharmaceutical 
Services within the municipal management of the Brazilian Unified Health System. 
METHODS: The Pesquisa Nacional sobre Acesso, Utilização e Promoção do Uso Racional de 
Medicamentos no Brasil – Serviços (PNAUM – National Survey on Access, Use and Promotion of Rational 
Use of Medicines – Services) is a cross-sectional, exploratory, and evaluative study that performed an 
information survey in a representative sample, stratified by Brazilian regions It considered different study 
populations in the sampling plan, which represent primary health care services in the cities. Data were 
collected in 2015 by two methods: in person, by applying direct observation scripts and interviews with 
users, physicians, and professionals responsible for the dispensing of medicines in primary care services; 
by telephone interviews with municipal health managers and municipal professionals responsible for 
Pharmaceutical Services. The results were extracted from the questionnaires applied by telephone.
RESULTS: Of the sample of 600 eligible cities, we collected 369 interviews (61.5%) with secretaries 
and 507 (84.5%) with pharmaceutical services managers. 70.8% of the cities have a computerized 
management system; and 11.9% have qualification/training of professionals. More than half (51.3%) 
of the cities received funds for the structuring of pharmaceutical services, and almost 60% of these 
cities performed this type of spending. In 35.4% of cases, municipal secretaries of health said that 
they use resources of medicines from the Componente Básico da Assistência Farmacêutica (CBAF – 
Basic Component of Pharmaceutical Services) to cover demands of other medicines, but only 9.7% 
believed that these funds were sufficient to cover the demands. The existence of a permanent 
bidding committee exclusively for acquiring medicines was reported in 40.0% of the cities.
CONCLUSIONS: We found serious deficiencies in the public financing of medicines, as well as 
little concern about the formality in the use of public resources, expenses that meet individual 
demands to the detriment of the community, insufficient resources allocated to the Basic 
Component of Pharmaceutical Services, and exhaustion of the financing model.
DESCRIPTORS: Pharmaceutical Services, economics. Healthcare Financing. Primary Health 
Care. Health Services Research. Unified Health System.
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INTRODUCTION
The financing of health systems has become a major challenge before the growing demand 
for health actions and services. The pharmaceutical spending has been settling as a real threat 
to the sustainability of public systems16. These expenses can be quite significant because of 
the high unit value of some medicines or by the large volume of items needed to meet the 
needs of the population. 
One way or another, these values are expressive before the set of total spending on health 
care, either on the account of citizens or Government. In 1996, medicines accounted for 
37% of the total spending of Brazilian families with health, becoming 47% in 200810. On the 
other hand, the spending forecast of the Brazilian Unified Health System (SUS) for the 
promotion and organization of Pharmaceutical Services (PS); maintenance and operation 
of the Popular Pharmacy Program ( free and co-payment); production of pharmaceuticals, 
medicines, and herbal medicines; acquisition and distribution of medicines of PS 
Components and for the treatment of HIV/AIDS and other sexually transmitted diseases 
totaled R$ 13.2 million for 2017, representing more than 11% of the total expenditures set 
out for the Brazilian Ministry of Health7. 
The Pesquisa Nacional Sobre Acesso, Utilização e Promoção do Uso Racional de 
Medicamentos – Serviços (PNAUM – National Survey on Access, Use and Promotion of 
Rational Use of Medicines – Services)11 aimed to characterize the organization of PS in SUS 
primary health care, focusing the promotion of access and rational use of medicines, as well 
as the identification and discussion of factors that compromise the consolidation of the PS in 
the cities. This study is part of PNAUM – Services and aimed to discuss factors related to the 
financing of the Componente Básico da Assistência Farmacêutica (CBAF – Basic Component 
of Pharmaceutical Services) in Brazilian cities.
METHODS
PNAUM – Services is a cross-sectional, exploratory, and evaluative study, consisting of a 
information survey in a representative sample of primary health care services in cities. The 
sample was stratified by the Brazilian regions, considering the different study populations 
in the sampling plan1. 
Data were collected from July 2014 to May 2015, by face-to-face and telephone interviews. 
In person, data were collected by applying direct observation scripts, interviews with patients, 
physicians, and professionals responsible for the dispensing of medicines in SUS primary 
health care services. By phone, data were collected using semi-structured questionnaires 
for municipal health managers and professionals responsible for PS in the cities, applied by 
interviews conducted by trained researchers, with computer-assisted telephone interview 
technology. All interviews, in-person or by telephone, were preceded by the signing of the 
informed consent form1.
The instruments aimed to know the organization of PS, including their financing and the 
local conduct on the use of financial resources destined to the CBAF. The results relevant to 
finance-related factors were extracted of the questionnaires applied to municipal secretaries 
of health and those responsible for the PS of the cities, listed in the following groups of 
variables: management of financial resources, use of computerized systems, professional 
training and qualification, ways of acquiring medicines and structuring PS. 
Statistical analysis included estimates of absolute and relative frequencies (with 95% 
confidence intervals). Group comparison was held by Pearson’s Chi-square test. Data analysis 
was performed with SPSS® software, version 22, using the plan of complex samples1.
The research project was approved by the National Research Ethics Committee, by Opinion 
no. 398,131, September 16, 2013. 
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RESULTS 
Of the calculated sample of 600 cities eligible for the study, 369 interviews were conducted 
(61.5%) with municipal secretaries of health and 507 (84.5%) with those responsible for PS. 
According to the secretaries, 54% of Brazilian cities have adopted the partial decentralization 
regime agreeing with the implementation of CBAF resources, followed by 30.8% who have 
adopted the fully decentralized regime (Figure 1). The PS coordination had full autonomy 
of management of the financial resources defined for PS in 22.7% of the cities, and partial in 
45.6%. Of the cities evaluated, 67.3% made expenses intended for the structuring of PS in the 
year preceding the research. CBAF resources were used to cover demands for medicines not 
belonging to this component by 35.4% of the cities. 9.7% of municipal secretaries of health stated 
that the resources intended for CBAF were sufficient to meet the demands of the population.
From the perspective of those responsible for PS, the PS coordination had full autonomy 
for managing financial resources in 19.7% of the cities, and partial autonomy in 38.2%. They 
reported that 70.8% of Brazilian cities had a computerized system for PS management, 
especially in the South region (88.8%). Activities for qualification and/or professional training 
for workers of PS occurred in 11.9% of the cities (Table 1).
More than half of the cities received, in the year preceding the survey, resources from the 
states or federal government aimed at the structuring of PS. Just over 50% of the cities made 
some expense with PS structuring. As stated by the interviewees, 86.4% of cities applied, 
in the year before the survey, the total value agreed of the corresponding credit of CBAF, 
compared with 72.7% of states (Table 1). When asked about the sufficiency of the CBAF’s 
financial resources to meet the demand of the city, about 37% of those responsible for PS 
in the South and Midwest regions evaluated it positively, while in the North and Northeast 
regions these percentages were only 13.6% and 21.8%, respectively (Figure 2).
The existence of a Comissão Permanente de Licitação (CPL – Permanent Bidding Committee) – 
exclusive for the purchase of medicines in the city –, was reported in 37.7% of cities, especially in 
the Midwest region, with 49%. When asked whether the Programa Farmácia Popular do Brasil 
(PFPB – Brazilian Popular Pharmacy Program) influenced the purchase of medicines carried out 
by the cities, 50.9% of them have registered affirmative responses. The North region presented the 
lowest index of interference (33.2%) and the Southeast, the largest one (61.7%). 66.6% of cities have 
purchased medicines to meet judicial demands in the year preceding the research. The Midwest 
region stood out with the highest index (75.3%) and the North region with the lowest (47.5%) (Table 1). 
 
 
Fully centralized
in the state
11%
Fully decentralized
for the city
31%
Partially decentralized
for the city
54%
Other
4%
 
PS: Pharmaceutical Services 
Source: PNAUM – Services, 2015.
Figure 1. Agreement form for the use of resources of the Basic Component of Pharmaceutical Services 
(CBAF) in the cities, according to municipal secretaries of health. National Survey on Access, Use and 
Promotion of Rational Use of Medicines – Services, 2015.
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The association between city and state was the most common partnership for purchasing 
medicines (26.2%), followed by consortium between cities (15.0%). The South region has 
adopted the strategy of consortia in 52.2% of the cities (Figure 3). Purchase of medicines 
carried out in local pharmacies/drugstores was registered in 58.3% of cities, with emphasis 
for the cities of the North, which had the highest percentage (73.4%) (Figure 4). 
Table 1. Data reported by those responsible for municipal Pharmaceutical Services, according to Brazilian regions. National Survey on 
Access, Use and Promotion of Rational Use of Medicines – Services, 2015.
Variable
Midwest North Northeast South Southeast Brazil
na % (95%CI) na % (95%CI) na % (95%CI) na % (95%CI) na % (95%CI) na % (95%CI)
The coordination of PS has autonomy in financial management 
Yes, fully 17 19.5 (12.4–29.2) 10 10.8 (5.6–19.6) 16 15.3 (8.7–25.3) 24 24.3 (16.7–33.9) 20 22.8 (15–33) 87 19.7 (15.7–24.4)
Yes, partially 30 30.9 (22.2–41.3) 22 25 (16.7–35.6) 35 38.4 (28–49.9) 43 42.3 (32.8–52.5) 38 39.8 (29.9–50.7) 168 38.2 (33–43.6)
Existence of a computerized system for the management of PSb
Yes 54 53.5 (43.5–63.3) 41 40.1 (30.5–50.5) 60 61.2 (50–71.4) 95 88.8 (80.9–93.7) 81 78.7 (69.2–85.8) 331 70.8 (66–75.1)
Existence, in the city, of some type of qualification and/or training for PS professionals
Yes 11 14.8 (8.4–24.9) 9 10.4 (5.3–19.2) 8 11.6 (5.6–22.4) 11 9.5 (4.8–17.8) 11 13.5 (7.6–22.8) 50 11.9 (8.6–16.2)
The city received resources (from the State or Federal governments) intended for structuring PS in the past year
Yes 23 43.2 (30.4–57) 23 35.8 (24.6–48.7) 37 60.6 (47.2–72.5) 27 42.1 (30.5–54.7) 35 53.9 (41.4–65.9) 145 51.3 (44.8–57.7)
The city spent with the structuring of PS in the past year
Yes 44 58.5 (47–69.1) 35 44 (32.9–55.8) 50 62.5 (50.5–73.2) 56 59.1 (48.4–69) 35 44.3 (33–56.2) 220 54.8 (49.1–60.5)
The city applied, in the past year, the total value agreed of the corresponding credit of the Basic Component of Pharmaceutical Services
Yes 37 85.3 (70.8–93.3) 41 73.7 (59.8–84.1) 46 80.5 (67–89.4) 59 92.7 (83–97) 63 90.2 (79.8–95.5) 246 86.4 (81.1–90.4)
The state applied, in the past year, the total value agreed on the corresponding entry of the Basic Component of Pharmaceutical Servicesb
Yes 25 77 (59.4–88.4) 22 57.2 (40.7–72.3) 27 49.9 (35.1–64.8) 47 86.8 (74.7–93.7) 54 84.2 (72.4–91.6) 175 72.7 (65.7–78.6)
Existence of a permanent bidding committee exclusively for the purchase of medicines in the city
Yes 43 49 (38.6–59.5) 34 41.4 (31.2–52.4) 26 33.6 (23.5–45.6) 40 36.9 (27.8–46.9) 39 38.1 (28.5–48.7) 182 37.7 (32.6–43)
The Popular Pharmacy Program influences the purchase of medicines by the cityb
Yes 54 56.1 (45.8–65.9) 32 33.2 (24.2–43.7) 29 35.9 (25.7–47.5) 61 58.4 (48.6–67.7) 60 61.7 (51.4–71.1) 236 50.9 (45.8–56)
The city purchased medicines to meet judicial demands in the past yearb
Yes 71 75.3 (65.3–83.2) 43 47.6 (36.7–58.6) 52 59 (46.3–70.6) 73 69.2 (59.1–77.7) 74 72.4 (62.3–80.7) 313 66.6 (61.3–71.5)
PS: pharmaceutical services
a N value non-weighted
b p < 0.05
Source: PNAUM - Services, 2015.
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21.8% 
27.0% 
37.4% 37.8% 
27.8% 
0.0%
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20.0%
30.0%
40.0%
The resources of the Basic Component of Pharmaceutical Services are sufficient to
meet the demand of the city (p < 0.05)
North Northeast Southeast South Midwest Brazil
Source: PNAUM – Services, 2015.
Figure 2. Adequate level of sufficiency of financial resources in the Basic Component of Pharmaceutical 
Services (CBAF) for meeting the demands, according to those responsible for Pharmaceutical 
Services, by regions and Brazil. National Survey on Access, Use and Promotion of Rational Use of 
Medicines – Services, 2015.
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DISCUSSION
Medicines are a vital input in health care22, as well as in the process of sustainability of health 
systems before the volume of financial resources to acquire these items16. In a scenario of 
finite resources and infinite demands, the need for proper management of the resources 
employed in PS is imperative. In this sense, the results achieved by PNAUM – Services help 
overcoming this challenge, since they allow one to know and to discuss the factors related 
to the management of financial resources within the CBAF. 
CBAF12 is intended for the purchase of medicines and supplies, as specified in Annex I and Annex IV 
of the Relação Nacional de Medicamentos Essenciais (Rename – National List of Essential Medicines), 
including those related to the diseases and health programs of primary health care, dedicated to 
meet the individual and collective basic needs of the population9. Other items are also part of 
CBAF: herbal medicines, homeopathic matrices and mother tinctures of Brazilian Homeopathic 
Pharmacopoeia, and the medicines listed in Group 3 of the PS Specialized Component. 
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
With municipal
consortium
With other cities With the state With other
institutions
North Northeast Southeast South Midwest Brazil
Source: PNAUM – Services, 2015
Figure 3. Partners that the cities have established for the purchase of medicines, according to the 
representatives of municipal Pharmaceutical Services, by regions and Brazil. National Survey on Access, 
Use and Promotion of Rational Use of Medicines – Services, 2015.
0.0%
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North Northeast Southeast South Midwest Brazil
Source: PNAUM – Services, 2015
Figure 4. Frequency of purchase of medicines in local pharmacies/drugstores by the cities, according 
to representatives of Pharmaceutical Services, by regions and Brazil. National Survey on Access, Use 
and Promotion of Rational Use of Medicines – Services, 2015.
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By establishing the sources of funds intended for financing CBAF, the state and municipal 
secretariats of health determine, in their respective Comissões Intergestores Bipartite 
(CIB – Bipartite Intermanagement Committees), the form of agreement for using the CBAF 
resources. According to data collected with secretaries of health, 11% of cities agreed to 
use CBAF resources centrally by the state manager, who took responsibility for acquisition, 
logistics, and supplies in the cities. Other 31% agreed on the completely decentralized form 
in municipal management and became responsible for the direct acquisition of the items. 
However, more than half (54%) chose the partially decentralized mode, which means that 
the state management of SUS maintained some responsibility for the medicines purchase, 
even allowing the cities to adhere to their Price Registration Proceedings6. 
We observed that the PS financial resource management was held autonomously by those 
responsible for PS in only 19.7% of cities, although most cities (70.8%) have a computerized 
system for PS management , which allows monitoring and control by the secretariat of health. 
Regarding purchases made by cities, 26.2% of them took place in partnership with the 
state secretariats of health, with emphasis on the Northeast (35.2%) and Southeast (28.9%) 
regions. We highlight the possibility of states in these regions establishing partnerships with 
the major public laboratories. The form of the acquisition accomplished by public consortia 
was adopted by 15% of the cities, especially in the South, where more than 50% of its cities 
adopted this form of purchase. The Consórcio Paranáa contributed heavily to this result, and 
the vast majority of cities of this state is associated with it. The North region was the one 
that reported the lowest rate of partnerships for medicines purchases.
Regardless of the scope of SUS management, all purchases of supplies and medicines should 
be carried out in agreement with the rules that control purchases, biddings, and contracts 
of the Public Administration3. Almost half of PS managers reported they always, repeatedly, 
or sometimes purchased medicines in local pharmacies or drugstores. Probably, this practice, 
which had the biggest instances recorded in the Midwest and South, was in disaccord with 
current standards. 
It is also the managers’ responsibility to register all financial resources related to PS in the 
Health Plan, in the Annual Schedule, and in the Annual Management Report, as well as to 
promote the monitoring of these resources, ensure the balance between responsibility and 
participation in the financing, and provide analyses with information on prices, quantities 
purchased, and number of patients met12.
Still regarding the purchase of medicines, we highlight the practice declared by 35.4% of 
secretaries: using CBAF resources to situations other than those reported in the agreements. 
Also, the fact that more than 66% of the cities have bought medicines intended to meet 
judicial demands is noteworthy. In fact, health litigation has the positive effect of ensuring 
access to medicines in shortage situations, even filling the lack of care or enabling the 
incorporation of new health technology. However, it represents a great challenge for SUS, 
as it puts at risk the achievement of the constitutional principles of the system and causes 
difficulties for PS management, which may compromise the quality of the use of medicines17. 
It is believed that this phenomenon is aggravated by the lack of trained human resources, 
which causes weaknesses in the management of the demands of the population, hindering 
the appropriate guidance to patients in the dispensing units, which ultimately start to 
operate to a limited extent, as a simple place to deliver medicines18. The fact that only 12% of 
the cities have registered investments in the training of professionals in PS can corroborate 
such understanding. 
A significant consequence of litigation is the disorganization of the health systemb, especially 
in the processes of acquisition, since judicial decisions are issued on the basis of urgency, 
forcing managers to often perform direct acquisitions in pharmacies or drugstores. Certainly, 
these acquisitions occur at an unfavorable price compared to other forms, which tends to 
a Consórcio Intergestores Paraná 
Saúde (Health Intermanagement 
Consortium of Parana), founded 
in 1999, constituted in the form 
of a public consortium, with legal 
personality under private law, not-
for-profit. It gathers 394 cities of 
the 399 of Paraná and carries out 
the acquisition of the medicines 
listed in the Basic Pharmaceutical 
Services of the state.
b Barroso LR. Da falta de 
efetividade à judicialização 
excessiva: direito à saúde, 
fornecimento gratuito de 
medicamentos e parâmetros 
para a atuação judicial. [cited 
2017 Jan 10]. Available from: 
http://www.conjur.com.br/dl/
estudobarroso.pdf
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aggravate one of the consequences of this phenomenon: the use of financial resources for 
the care of individual needs rather than collective needs19,b.
Still concerning the disorganization of the supplies and medicines purchase, our results 
showed the interference of PFPB in the acquisition of CBAF medicines. The PFPB was created 
with the purpose of broadening citizens’ access to essential medicines for the treatment 
of the most common diseases, by the accreditation of private drugstores, promoting the 
dispensing of medicines free of charge and/or in co-payment system4. The financing of these 
medicines takes place by the transfer of resources from the Brazilian Ministry of Health to the 
accredited establishments13. In this context, and given a scenario of insufficient resources, 
municipal secretariats of health may choose not to purchase the list of products offered by the 
PFPB. It must be considered that the acquisition by cities can be impaired depending on the 
ability of manufacturers to meet both public and private networks, either by the limitation of 
production or by the practicality in the process of selling with prices without the discounts 
conditioned to the sales for the Government. Still, apart from the aspect of organization of 
processes, the economic aspect must be considered. Recent real world evidence registered 
that the direct production of PS by the public sector, carried out by a network of its own, 
is economically more favorable given the outsourcing of PFPB services8. 
The results related to the funding for structuring and maintaining PS are worrisome. Little more 
than half of the cities (54.3%) spent in this area, even with the record that 51.3% of cities received 
some type of financial incentive from the federal or state government. Even lower rates were 
verified for the investment in qualification and/or professional training for PS workers. This 
scenario shows a progressive dismantling of the services rendered, in contrast with the fact 
that, since 2010, it is possible to use up to 15% of the state and municipal resources to finance 
PS improvements, namely: adjustment of the infrastructure of SUS pharmacies, acquisition 
of equipment and furniture to support PS actions, and promotion of activities linked to the 
continuing education and qualification of human resources14. 
As a way of supporting the national qualification of PS, the Brazilian Ministry of Health 
instituted, in 2012, the Programa Nacional de Qualificação da Assistência Farmacêutica no 
Âmbito do SUS (QUALIFAR-SUS – National Program for Qualification of Pharmaceutical 
Services of SUS), prioritizing cities of up to 100,000 inhabitants classified in the range of 
extreme poverty. The program was organized into four areas: infrastructure, education, 
information, and care. The funding takes place by the transfer of federal resources destined 
to acquisition of furniture and equipment required for the structuring of public Centrais 
de Abastecimento Farmacêutico (CAF – Pharmaceutical Supply Centers) and Pharmacies 
in primary health care, in addition to the maintenance of pharmaceutical services. Until 
2016, resources were destined to 1,582 cities, totaling 28% of the Brazilian cities. The 
investment resource, delivered in a single installment, varies, by population, between 
R$11.2 thousand and R$24 thousand. The total resource cost is R$ 24 thousand/year, 
delivered in quarterly form. Although it is an important and necessary program, it shows 
small impact, either as a source of PS financing or by the number of cities covered – 
mainly by the low population coverage achieved.
The PS in SUS are funded with municipal, state, and federal budgets, according to the 
peculiarities of their components: basic, specialized, or strategic. The CBAF is financed with 
resources from the three levels of government and has application of minimum values, per 
inhabitant/year, based on the population of each city12. The resources are transferred monthly 
from the federal level to states and from these to the cities, or from the federal government 
directly to the cities, depending on the type of municipal management agreed. Similarly, there 
are transfers from the states to the cities, and also there can be the supply of medicines. Besides 
the transfers from the federal and state governments, one should also consider the resources 
from the municipal treasury. In addition to the agreed tripartite values, it is responsibility of 
the Brazilian Ministry of Health to finance, acquire, and distribute insulin, contraceptives, and 
supplies of the Women’s Health Program, as well as to finance, by annual transfers to states, 
the medicines purchase in the context of Indigenous Health and in the Política Nacional de 
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Atenção Integral à Saúde das Pessoas Privadas de Liberdade no Sistema Prisional (PNAISP – 
National Policy of Integral Health Care for Persons Deprived of Liberty in the Prison System).
Between 1999 and 2016, a 390% increase was registered in the minimum value per capita/year 
of tripartite financing of CBAF14. Similarly, between 2005 and 2009, there was a 61% increase in 
the total amount spent for purchase of medicines by the three spheres of SUS management21. 
According to our results, 72.7% of the states and 86.4% of the cities applied the total value 
agreed to finance the CBAF. However, only 9.7% of secretaries of health consider the financial 
resources intended for the CBAF sufficient to meet the population’s needs. What actually 
happens is that the values for the CBAF are outdated, especially by the SUS federal manager, 
responsible for over 50% of the funding. The financial gap, in detriment to the possibility of 
states and cities having increased values in agreements in the respective CIB, exceeds 50%, 
when applied to the Broad Consumer Price Index, and becomes even greater if we consider the 
estimated population growth in the period, more than 12 million peoplec. The discrepancies 
were exacerbated in 2013, when some medicines of other components migrated to the CBAF, 
without their respective financial contribution15. In this sense, the cities increased their own 
resources for public health actions and services (ASPS) and for per capita expenses with 
medicines. Between 2010 and 2016, the average percentage of expenses with ASPS jumped from 
20.37 to 23.27%d, above the 15% recommended by the Federal Constitution. Between 2010 and 
2015, the median medicines per capita expenses of the cities jumped from R$ 15.71 to R$ 21.04d. 
Despite the freezing of PS resources, the complete exhaustion of the current model of PS 
financing takes place, derived from the model of SUS financing. The findings of this research 
base this understanding as well as the law 141/20125, which regulated, to the financing of 
the system, the mandatory use of apportionment criteria for the resources of the federal 
and state governments transferred to other entities, aiming at the progressive reduction 
of regional disparities. The apportionment of resources linked to ASPS, included there the 
financing of all primary health care, must consider the health needs of the population, the 
epidemiological, demographic, socio-economic, and spatial dimensions, as well as the ability 
to offer health actions and services, and also the combination of the criteria governed by 
the Law2. Additionally, it must employ a method of calculation that considers a general 
index, built upon the health needs, health care networks, and technical performance of 
ASPS execution for each of the management levels20. As established in law, this is a funding 
model agreed and standardized for PS, as well as for the SUS, since 2012. 
The application of the questionnaire by telephone is a limitation of this research, because 
it could not allow the respondent access or query to auxiliary material. Also, this is a 
cross-sectional study, which reflects only the moment of the survey, not enabling the 
establishment of temporal relationships between the results found.
Finally, the results observed in this study show serious deficiencies in the financing and 
management of the CBAF financial resources. Among these, we highlight: little concern with the 
formality in the execution of public resources, either by evidence of acquisition or destination of 
resources outside of the regulatory standards or by the non-application by the states and cities 
of their respective corresponding credits; expenses incurred for meeting individual demands to 
the detriment of collective ones, and; statement of most managers that the resources intended 
for the CBAF are insufficient to cover needs and demands of the population. The fact that the 
main financial incentive of PS is below by more than 50% in its value since 2010 corroborates 
this understanding, as well as the finding, depending on the results obtained and due to legal 
regulations, of the exhaustion of the current model of PS financing. 
In the context of the CBAF, major challenges have not yet been overcome. Considering the 
multiplicity of responsibilities between the management levels of the SUS to ensure the 
population’s access to medicines in primary health care, addressing these challenges requires 
revising the PS financing model, the Política Nacional de Medicamentos (PNM – National 
Drug Policy), and the Política Nacional de Assistência Farmacêutica (PNAF – National Policy 
of Pharmaceutical Services). 
c Brazilian Institute of Geography 
and Statistics. The total 
population, men and women 
2000-2030. Rio de Janeiro: 
IBGE; 2013 [cited December 
11, 2016]. Available from: 
http://www.ibge.gov.br/home/
estatistica/populacao/projecao_
da_populacao/2013/.
d Ministry of Health (BR). 
DATASUS.SIOPS - Information 
System on Public Budgets in 
Health. Municipal indicators: 
3.2% of own resources applied 
in health (EC 29) and 2.3% 
Medicines Expenditure/Total 
Expenditure. [cited 2017 Jan 10]. 
Available from: http://siops-asp.
datasus.gov.br/CGI/deftohtm.
exe?SIOPS/serhist/municipio/
mIndicadores.def
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